Form 4 for DGX Quest Diagnostics
Accepted 2025-05-14 00:00:00 ET · period of report 2025-05-12 · accession 0001022079-25-000132 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-05-14 | 2025-05-12+ | DGX | DELANEY MARK E | SVP, Chief Commercial Off | S - Sale | $175.51 | -1,748 | 7,498 | -19% | -$306.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-12 | S | D | 874 | $175.72 | 8,372 | D | — | — | |
| 2 | Common | Common Stock | 2025-05-13 | S | D | 874 | $175.31 | 7,498 | D | — | — |